LetCOH as effective as cCOH for fertility preservation in nonmetastatic BCSeptember 19, 2022Breast Cancer
ER+/HER2+ BC: HER2-enriched subtype predicts poor response to AI therapySeptember 19, 2022Breast Cancer
Risk for brain metastasis highest with ERBB2+ and triple-negative metastatic BCSeptember 19, 2022Breast Cancer
Reassuring survival outcomes with trastuzumab+lapatinib in small and node-negative HER2+ BCSeptember 19, 2022Breast Cancer
Neratinib alone or in combination with capecitabine beneficial for advanced HER2+ BC September 19, 2022Breast Cancer
Early TNBC: Durvalumab+NACT improves survival despite modest pCR increaseSeptember 19, 2022Breast Cancer
De-escalation of locoregional radiotherapy after primary chemotherapy appears safe in cT1-2N1 BCSeptember 19, 2022Breast Cancer
Oncology PracticeTime to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
Hematology NewsFDA warns of cancer risk in scar tissue around breast implantsSeptember 14, 2022Nonmelanoma Skin CancerMixed TopicsBreast Cancer
Oncology PracticeSex is still a taboo subject for patients with breast cancerSeptember 13, 2022Breast Cancer
Oncology PracticeStronger evidence that exercise lowers breast cancer riskSeptember 7, 2022Breast CancerPreventive Care
